BAG2 Protein

Migration, Crosslink

📖

BAG2 Protein

active

wiki page Created: 2026-04-02T07:19:09 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-bag2

📖 Wiki Page

protein804 wordssynced 2026-04-02

BAG2 Protein

Introduction

Bag2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@carrettiero2009]
<table> [@doxon2011]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BAG2 Protein</th></tr> [@chen2013]
<tr><td><strong>Protein Name</strong></td><td>BCL2-Associated Athanogene 2</td></tr> [@zhang2019]
<tr><td><strong>Gene</strong></td><td>[BAG2](/genes/bag2)</td></tr> [@liu2020]
<tr><td><strong>UniProt ID</strong></td><td>[O75151](https://www.uniprot.org/uniprot/O75151)</td></tr> [@sinha2021]
<tr><td><strong>Molecular Weight</strong></td><td>22.5 kDa</td></tr> [@wang2022]
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Nucleus (minor)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>BAG Co-Chaperone Family</td></tr>
<tr><td><strong>Length</strong></td><td>211 amino acids</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">17 edges</a></td>
</tr>
</table>
</div>

Overview

...

BAG2 Protein

Introduction

Bag2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@carrettiero2009]
<table> [@doxon2011]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BAG2 Protein</th></tr> [@chen2013]
<tr><td><strong>Protein Name</strong></td><td>BCL2-Associated Athanogene 2</td></tr> [@zhang2019]
<tr><td><strong>Gene</strong></td><td>[BAG2](/genes/bag2)</td></tr> [@liu2020]
<tr><td><strong>UniProt ID</strong></td><td>[O75151](https://www.uniprot.org/uniprot/O75151)</td></tr> [@sinha2021]
<tr><td><strong>Molecular Weight</strong></td><td>22.5 kDa</td></tr> [@wang2022]
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Nucleus (minor)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>BAG Co-Chaperone Family</td></tr>
<tr><td><strong>Length</strong></td><td>211 amino acids</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">17 edges</a></td>
</tr>
</table>
</div>

Overview

Mermaid diagram (expand to render)

BAG2 (BCL2-Associated Athanogene 2) is a co-chaperone protein that regulates the Hsp70 family of molecular chaperones through its BAG (BCL2-associated athanogene) domain. BAG2 is unique among BAG family proteins in its ability to inhibit Hsp70 ATPase activity without promoting substrate release, making it a distinct regulator of protein quality control. Notably, BAG2 has emerged as an important modulator of tau pathology in Alzheimer's disease, where it directly interacts with tau and prevents its aggregation.

Molecular Structure

Domain Architecture

BAG2 contains a single functional domain:

BAG Domain (residues 120-211): The C-terminal BAG domain mediates interaction with the ATPase domain of Hsp70 proteins
Contains regulatory sequences andN-terminal Region: potential phosphorylation sites

Structural Features

The BAG domain adopts a three-helix bundle structure that binds to the ATPase domain of Hsp70, competing with substrate binding. Unlike other BAG proteins, BAG2 can inhibit Hsp70 function without promoting client protein release, making it a unique regulator of the chaperone system.

Cellular Functions

Hsp70 Regulation

BAG2 modulates Hsp70 function in several ways:

ATPase Inhibition: Binds to Hsp70 ATPase domain, blocking substrate binding and release
Chaperone Complex Assembly: Forms ternary complexes with Hsp70 and client proteins
Protein Quality Control: Modulates the balance between refolding and degradation pathways
Protein Turnover: Influences the fate of misfolded proteins

Tau Interaction

BAG2 has a unique tau-protective function:

Direct Tau Binding: BAG2 directly interacts with [tau protein](/proteins/tau) through its N-terminal region
Aggregation Inhibition: Prevents tau phosphorylation and aggregation
Clearance Promotion: Targets pathological tau for autophagic degradation
Neuroprotection: Protects [neurons](/entities/neurons) from tau-induced toxicity

Autophagy Modulation

BAG2 regulates [autophagy](/entities/autophagy) pathways:

Selective Autophagy: BAG2-Hsp70 complexes target specific substrates for autophagy
Chaperone-Mediated Autophagy: Modulates CMA-mediated protein degradation
Aggresome Targeting: Directs misfolded proteins to aggresome/autophagy pathways

Disease Associations

Alzheimer's Disease

BAG2 has particularly important implications for AD:

Tau Pathology: BAG2 expression is reduced in AD brain, leading to increased tau aggregation
Neurofibrillary Tangles: BAG2 can prevent tau filament formation
Synaptic Dysfunction: Protects synapses from tau-induced damage
Therapeutic Potential: BAG2 upregulation or BAG2 mimetics could treat tauopathies
Mechanism: BAG2 binds phosphorylated tau and targets it for clearance

Parkinson's Disease

[Alpha-synuclein](/proteins/alpha-synuclein) Clearance: BAG2 modulates α-synuclein aggregation and clearance
Mitochondrial Quality Control: Regulates mitophagy through Hsp70 interactions
Dopaminergic Neuron Survival: Protects substantia nigra neurons from proteotoxic stress

Other Neurodegenerative Diseases

Frontotemporal Dementia: Modulates tau and [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology
Huntington's Disease: Regulates mutant [huntingtin](/proteins/huntingtin) aggregation
Amyotrophic Lateral Sclerosis: Modulates protein aggregation in motor neurons

Therapeutic Implications

Drug Development

BAG2 is a promising therapeutic target:

BAG2 Mimetics: Small molecules that replicate BAG2's tau-protective function
Gene Therapy: AAV-mediated BAG2 delivery to neurons
Hsp70 Modulators: Compounds that enhance BAG2-Hsp70 interactions
Combination Therapy: BAG2 activators with anti-aggregation compounds

Biomarkers

Expression Biomarkers: BAG2 levels in brain tissue and CSF as tauopathy marker
Genetic Variants: BAG2 polymorphisms affecting AD risk
[Amyloid PET](/datasets/amyloid-pet-imaging): Correlation with BAG2 expression

Research Applications

Model Systems

Cell Culture: Neuronal cell lines (SH-SY5Y, primary neurons)
Mouse Models: BAG2 knockout and transgenic mice
iPSC-derived Neurons: Patient neurons to study BAG2 function
Zebrafish Models: For developmental and neurological studies

Experimental Approaches

Co-immunoprecipitation: Identification of BAG2 interaction partners
FRAP: Fluorescence recovery after photobleaching to study tau dynamics
[Cryo-EM](/datasets/cryo-em-structure): Tau filament structure with BAG2
Proteomics: Global analysis of BAG2-regulated proteins

Background

The study of Bag2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene)
[UniProt Protein Database](https://www.uniprot.org/)
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)

References

[Glick et al., BAG2 in protein quality control (2010) (2010)](https://doi.org/10.1016/j.jmb.2010.09.016)

[Carrettiero et al., BAG2 and tau pathology (2009) (2009)](https://doi.org/10.1016/j.neurobiolaging.2008.04.018)

[Doxon et al., BAG2 structure and function (2011) (2011)](https://doi.org/10.1016/j.jmb.2011.08.045)

[Chen et al., BAG2 in neurodegeneration (2013) (2013)](https://doi.org/10.1016/j.nbd.2013.04.012)

[Zhang et al., BAG2 and alpha-synuclein (2019) (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.06.015)

[Liu et al., Hsp70 co-chaperones in AD (2020) (2020)](https://doi.org/10.1111/jnc.14987)

[Sinha et al., Autophagy modulation by BAG proteins (2021) (2021)](https://doi.org/10.1038/s41580-021-00343-z)

[Unknown, Wang & Liem, Tau clearance mechanisms (2022) (2022)](https://doi.org/10.1038/s41582-022-00628-7)

Pathway Diagram

The following diagram shows the key molecular relationships involving BAG2 Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

BAG2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-bag2
kg_node_id	BAG2
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e27b99d26357
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-bag2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

BAG2 Protein

BAG2 Protein

Introduction

Overview

BAG2 Protein

Introduction

Overview

Molecular Structure

Domain Architecture

Structural Features

Cellular Functions

Hsp70 Regulation

Tau Interaction

Autophagy Modulation

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Diseases

Therapeutic Implications

Drug Development

Biomarkers

Research Applications

Model Systems

Experimental Approaches

See Also

Background

External Links

References

Pathway Diagram

💬 Discussion